MIRA INFORM REPORT

 

 

Report Date :

30.10.2013

 

IDENTIFICATION DETAILS

 

Name :

NATCO PHARMA (CANADA) INC.

 

 

Registered Office :

Sussex Centre, Ste 401, 50 Burnhamthorpe, Ontario L5B 3C2

 

 

Country :

Canada

 

 

Date of Incorporation :

07.11.2012

 

 

Legal Form :

Federal Corporation – Profit

 

 

Line of Business :

Subject established to bring in and market, affordable, high quality pharmaceuticals to the Canadian market.

 

 

No. of Employees :

2

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

----

NB

New Business

----

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March, 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

Canada

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

canada - ECONOMIC OVERVIEW

 

As a high-tech industrial society in the trillion-dollar class, Canada resembles the US in its market-oriented economic system, pattern of production, and affluent living standards. Since World War II, the impressive growth of the manufacturing, mining, and service sectors has transformed the nation from a largely rural economy into one primarily industrial and urban. The 1989 US-Canada Free Trade Agreement (FTA) and the 1994 North American Free Trade Agreement (NAFTA) (which includes Mexico) touched off a dramatic increase in trade and economic integration with the US its principal trading partner. Canada enjoys a substantial trade surplus with the US, which absorbs about three-fourths of Canadian exports each year. Canada is the US's largest foreign supplier of energy, including oil, gas, uranium, and electric power. Given its great natural resources, highly skilled labor force, and modern capital plant, Canada enjoyed solid economic growth from 1993 through 2007. Buffeted by the global economic crisis, the economy dropped into a sharp recession in the final months of 2008, and Ottawa posted its first fiscal deficit in 2009 after 12 years of surplus. Canada's major banks, however, emerged from the financial crisis of 2008-09 among the strongest in the world, owing to the financial sector's tradition of conservative lending practices and strong capitalization. Canada achieved marginal growth in 2010-12 and plans to balance the budget by 2015. In addition, the country's petroleum sector is rapidly becoming an even larger economic driver with Alberta's oil sands significantly boosting Canada's proven oil reserves, ranking the country third in the world behind Saudi Arabia and Venezuela.

 

Source : CIA

 

Company name and address

 

Company name:            NATCO PHARMA (CANADA) INC.

Address:                       Sussex Centre, Ste 401, 50 Burnhamthorpe, Ontario L5B 3C2 Canada

Telephone:                    +1 905-593-1566

Fax:                              +1 905-593-1566

Website:                       www.natcopharma.ca

 

 

Company summary

 

Corporate ID#:                8344744

State:                           Federal

Judicial form:                 Federal Corporation – Profit

Date incorporated:          November 7, 2012

Stock:                            -

Value:                            -

Name of manager:          Bhaskara NARAYANA

 

 

ACTIVITIES & OPERATIONS

 

IST

 

Business:

 

NATCO PHARMA (CANADA) Inc. was established in the year 2012, to bring in and market, affordable, high quality pharmaceuticals to the Canadian market.

 

The Company is a subsidiary of NATCO PHARMA LTD. an Indian pharmaceutical company established in 1981. The Canadian Company has a professional set up with expertise in Quality systems, Regulatory requirements, Warehousing and logistics, Marketing, Distribution and Sales to serve the Canadian market.

 

Staff:     2

 

Operations & branches:

 

At the headquarters, we find the corporate office.

 

 

SHAREHOLDERS & MANAGERS

 

Shareholders:

 

NATCO PHARMA LTD.

Road No.2, Banjara Hills
Hyderabad-500 033 - India

 

Management:

 

MADHUSUDHAN VENKATACHARI

 

Madhusudhan VANKATACHARI, CEO and Officer

 

Bhaskara NARAYANA, Director and CFO

 

Subsidiaries

And partnership:                        None

 

 

FINANCIALS

 

In Canada, privately held corporations are not required to publish any financials.

 

On a direct call, nobody was available to answer our questions.

We sent an email but no answer received.

 

No financial available.

 

 

Banks:  n/a

           

 

LEGAL FILINGS

 

Legal filings & complaints:

 

As of today date, there is no legal filing pending with the Courts.

 

Secured debts summary:   None

 

Haut du formulaire

 

 

COMPANY CREDIT HISTORY

 

No trade references available.

 

No domestic credit history.

 

Our opinion:

 

Due to the lack of information, we are unable to estimate a risk.

 

 

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.61.46

UK Pound

1

Rs.98.99

Euro

1

Rs.84.72

 

 

INFORMATION DETAILS

 

Report Prepared by :

SDA

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.